Read the full story at The Hindu
This is a headline and a short summary only. The full article, photographs and reporting belong to The Hindu, so it opens on their website.
Read the full story at The Hindu →The Paragraph IV certification sought is with respect to applicable patents listed in the U.S. FDA’s Orange Book. Granules said it has also issued the requisite notice to the relevant parties in accordance with U.S. regulatory requirements.
Indian News is a news aggregator. The headline, this summary and the link are taken from
The Hindu’s public news feed, which the publisher offers for exactly this
purpose. Nothing has been rewritten, and no article text or photograph is stored on this site.